David Hodes is a cannabis business and lifestyle journalist based in the Washington D.C. metropolitan area. He is the former editor of seven different business magazines, and has contributed feature articles to several general business/lifestyle publications as well as 11 national cannabis publications including Sensi, Dope, Leafly, Cannabis Science and Technology, Cannabis Business Executive and others. He was named the 2018 Journalist of the Year by Americans for Safe Access, the largest medical cannabis advocacy organization in the world, and has moderated and/or presented sessions at six national and international cannabis business conferences. Hodes is member of the National Press Club, and deputy booking agent for the National Press Club Headliners Committee.
The Fresh Toast
Follow us for all the lastest entertainment and news with a side of cannabis
other Featured Stories
The first testing of marijuana for THC did not begin until the early 1970s. Here is where it gets a little bit more complicated.
Clearing up the genetic structure of a certain cannabis strain is top of the agenda for researchers.
How is a cop supposed to tell the difference between a consumer using a legal product, and an illegal consumer using or transporting a product from the illicit market?
Olivetol competes with THC for binding to the CB1 receptor, which is the receptor in the human body responsible for the psychoactive effects of THC.
As with any new product made from CBD, manufacturers can make any claim about what their infused product can do.
Three of the current presidential candidates claim that, if elected, they will legalize marijuana at the federal level. This would not just be rescheduling it, but completely taking if off the DEA's list of controlled substances.
Investing in marijuana stocks is risky these days, so why is CalPERS sinking more money into major cannabis companies?